JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 13 February 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.02022-07v1
82/9/4533    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smith-Donald, B. A.
Right arrow Articles by Roizman, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smith-Donald, B. A.
Right arrow Articles by Roizman, B.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.02022-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

The interaction of herpes simplex virus 1 regulatory protein ICP22 with the cdc25C phosphatase is enabled in vitro by viral protein kinases US3 and UL13

Benjamin A. Smith-Donald and Bernard Roizman*

Marjorie B. Kovler Viral Oncology Laboratories, The University of Chicago, 910 East 58th Street, Chicago, Illinois 60637

* To whom correspondence should be addressed. Email: bernard.roizman{at}bsd.uchicago.edu.


   Abstract

Earlier studies have shown that ICP22 and the UL13 protein kinase but not the US3 kinase are required for optimal expression of a subset of late ({gamma}2) genes exemplified by UL38, UL41 and US11. In primate cells ICP22 mediates the disappearance of inactive isoforms of cdc2, and degradation of the cyclins A and B1. The active cdc2 acquires a new partner, the viral DNA synthesis processivity factor UL42. Cdc2-UL42 complex recruits and phosphorylates topoisomerase II{alpha} for efficient expression of the {gamma}2 genes listed above. In uninfected cells the cdc25C phosphatase activates cdc2 by removing two inhibitory phosphates. The accompanying report shows in the absence of cdc25C, the rate of degradation of cyclin B1 is similar to that occurring in in infected wild-type mouse embryo fibroblast cells but the levels of cdc2 increased, and the accumulation of a subset of late proteins and virus yields are reduced. This report links ICP22 with cdc25C. We show that in infected cells ICP22 and US3 protein kinase mediate the phosphorylation of cdc25C at its C-terminal domain. In in vitro assays with purified components both UL13 and US3 viral kinases phosphorylate cdc25C and ICP22. Cdc25C also interacts with cdc2. However in infected cells the ability of cdc25C to activate cdc2 by dephosphorylation of inactive cdc2 protein is reduced. Coupled with the phosphorylation of cdc25C by the US3 kinase, the results raise the possibility that HSV-1 diverts cdc25C to perform functions other than those performed in uninfected cells.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.